April 9, 2004
Two Panels Recommend Improved Oversight of Research on Children
The federal government should improve and clarify its rules for research projects that study drugs and other therapies for children, according to new recommendations from two advisory bodies. Universities and other research institutions currently interpret the rules differently, says one of the reports, from the Institute of Medicine.
The advice comes at a time when studies using children as research subjects are on the rise. Congress has encouraged pharmaceutical companies to do such
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
